# US 2022/0008629 A1 · Non-biodegradable anti-adhesion material

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0008629 A1
- Document ID: US20220008629A1
- Status: Published application
- Kind: A1
- Application number: 17/289,083
- Filed: 2019-10-21
- Published: 2022-01-13
- Earliest claimed: 2018-10-31
- Assignees: Hi-Lex Corporation
- Applicants: Hi-Lex Corporation
- Inventors: Yasuharu Noishiki
- Web page: https://patentgrep.com/patent/US20220008629A1

## CPC

- A61L 31/041: {Mixtures of macromolecular compounds}
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A61B 90/02: {Devices for expanding tissue, e.g. skin tissue (implements for holding wounds open, surgical tractors A61B17/02; implantable mammary prosthesis A61F2/12; dilators A61M29/00)}
- A61L 31/042: {Polysaccharides}
- A61L 31/048: {obtained by reactions only involving carbon-to-carbon unsaturated bonds (A61L31/041 takes precedence)}
- A61L 31/06: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)}
- A61L 31/14: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61F 2/0063: {Implantable repair or support meshes, e.g. hernia meshes}
- A61F 2002/009: {for hindering or preventing attachment of biological tissue}
- A61F 2250/0059: temporary
- A61L 2300/236: Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
- A61L 2300/42: Anti-thrombotic agents, anticoagulants, anti-platelet agents
- A61L 2300/424: Anti-adhesion agents
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

The purpose of the present invention is to inhibit and prevent the formation of adhesions, i.e., bonds between a wound and its surrounding tissues or between organs that are originally separated. The anti-adhesion material of the present invention is characterized in that at least a part of the anti-adhesion material is made of a non-biodegradable material and a contact angle of a surface to water is less than 7 degrees or more than 90 degrees.

## Claims

### Claim 1

An anti-adhesion material, wherein at least a part of the anti-adhesion material is made of a non-biodegradable material and a contact angle of a surface to water is less than or equal to 7 degrees or greater than or equal to 90 degrees.

### Claim 2 (depends on 1)

The anti-adhesion material as claimed in claim 1, wherein at least the part of the anti-adhesion material is made of the non-biodegradable material, and the anti-adhesion material is to be removed from a body within 30 days after implantation.

### Claim 3 (depends on 1)

The anti-adhesion material as claimed in claim 1, wherein the anti-adhesion material has an anti-adhesion part and a grasping part for withdrawal outside a body within 30 days after surgery.

### Claim 4 (depends on 3)

The anti-adhesion material as claimed in claim 3, wherein the grasping part can be identified from a surrounding tissue by either ultrasonography, radiography, or palpation.

### Claim 5 (depends on 3)

The anti-adhesion material as claimed in claim 3, wherein the grasping part is at least one type selected from a group consisting of a string, a membrane, a button, a wire, a fiber, a cloth, a mesh, and their combined state, or is a deformed part of the anti-adhesion part.

### Claim 6 (depends on 3)

The anti-adhesion material as claimed in claim 3, wherein at least a part of the grasping part and the anti-adhesion part is made of in vivo non-biodegradable material and has neither cytotoxicity nor cell adhesion.

### Claim 7 (depends on 3)

The anti-adhesion material as claimed in claim 3, wherein the anti-adhesion part binds or contains at least one selected from heparin, polyhydric alcohol, urokinase, tissue plasminogen, polyethylene glycol, polyvinyl alcohol, and vinylon.

### Claim 8 (depends on 3)

The anti-adhesion material as claimed in claim 3, wherein the anti-adhesion part and the grasping part are at least one selected from a group consisting of a membrane, a string, a tube, a rod, and a mesh, or a combination thereof.

### Claim 9 (depends on 3)

The anti-adhesion material as claimed in claim 3, wherein the anti-adhesion part is membranous and has convergent property, tissue slidability, and tensile strength of greater than or equal to 20 kPa (test method: JIS Z1702) for withdrawal outside the body through a small hole of 2 cm or less in diameter.

### Claim 10 (depends on 3)

The anti-adhesion material as claimed in claim 3, wherein the anti-adhesion part has a membrane shape and a peripheral portion of the anti-adhesion part has a membrane expansion and maintenance part such as a part with high rigidity compared to the central part of the anti-adhesion part, a part with a steel wire, a part with a tube, etc.

### Claim 11 (depends on 10)

The anti-adhesion material as claimed in claim 10, wherein the membrane expansion and maintenance part has a steel wire made of a shape memory alloy, or a piano wire, or a wire having a similar stiffness and flexibility thereto.

### Claim 12 (depends on 10)

The anti-adhesion material as claimed in claim 10, wherein a membrane expansion state is maintained by injecting a liquid into a tube arranged in the membrane expansion and maintenance part.

### Claim 13 (depends on 3)

The anti-adhesion material as claimed in claim 3, wherein the anti-adhesion part has a membrane shape and is inserted during surgery into any one of an abdominal cavity, a thoracic cavity, a pericardial cavity, or an intracranial space, and the grasping part is used by penetrating an abdominal wall, a thoracic wall, a skull, or the like and being fixed in a subcutaneous tissue just below a skin.

### Claim 14 (depends on 3)

The anti-adhesion material as claimed in claim 3, wherein the anti-adhesion part is inserted into any one of a tubular tissue such as a tear duct, a ureter, a urethra, a tendon sheath, etc., and the grasping part is fixed in a subcutaneous tissue just below a skin.

### Claim 15 (depends on 13)

The anti-adhesion material as claimed in claim 13, wherein the anti-adhesion part inserted during surgery can be exposed and grasped by a small incision in the skin where the grasping part is located within a predetermined period of time after surgery, and can be pulled out of the body to prevent late adhesion.

### Claim 16 (depends on 14)

The anti-adhesion material as claimed in claim 14, wherein the anti-adhesion part inserted during surgery can be exposed and grasped by a small incision in the skin where the grasping part is located within a predetermined period of time after surgery, and can be pulled out of the body to prevent late adhesion.
